Fig. 4

Imaging changes in measurable intracranial metastases in 2 patients after T-DXd treatment. T-DXd, trastuzumab deruxtecan.
Imaging changes in measurable intracranial metastases in 2 patients after T-DXd treatment. T-DXd, trastuzumab deruxtecan.